logo

For the Inventor, By the Inventor

North Bethesda, MD, United States of America

Gilbert Jay

This inventor holds 8 USPTO granted patents. Top assignee: Origene Technologies, Inc.. Active years: 2001-2006.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Gilbert Jay. Retrieved from https://idiyas.com/inventor/gilbert-jay

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 8

% Patents Active = 87.5

Average Co-Inventor Count = 3.2

ph-index = 3

Forward Citations = 37(Granted Patents)


Location History:

  • Gaithersburg, MD (US) (2001)
  • North Bethesda, MD (US) (2002 - 2006)

Company Filing History:

goldMedal8 out of 9 
 
Origene Technologies, Inc.
 patents

Years Active: 2001-2006

Loading Chart...
8 patents (USPTO):Explore Patents
1. 7115393 - Melanocortin-1 receptor and methods of use (2006-10-03),
2. 7053193 - Breast cancer transcription factor gene and uses (2006-05-30),
3. 6953673 - Histamine H2 receptor and uses (2005-10-11),
4. 6833247 - Regulated prostate cancer genes (2004-12-21),
5. 6780595 - Human Tbx20 gene and uses (2004-08-24),
6. 6657054 - Regulated angiogenesis genes and polypeptides (2003-12-02),
7. 6455292 - Full-length serine protein kinase in brain and pancreas (2002-09-24),
8. 6316193 - Rapid-screen cDNA library panels (2001-11-13),

Title: The Innovations of Gilbert Jay

Introduction

Gilbert Jay is a prominent inventor based in North Bethesda, MD (US), known for his significant contributions to the field of biotechnology. With a total of 8 patents to his name, he has made remarkable advancements in medical research and therapeutic applications.

Latest Patents

Among his latest patents is the invention related to the Melanocortin-1 receptor and methods of use. This invention encompasses novel polynucleotides for melanocortin-1 receptors, the polypeptides they encode, and their applications in research, diagnosis, drug discovery, therapy, and clinical medicine. The polynucleotides serve various purposes, including acting as molecular markers and drug targets, particularly in relation to diseases such as melanoma and pigmentation disorders. Another significant patent is focused on the Breast cancer transcription factor gene and its uses. This invention also involves novel polynucleotides and their applications in detecting and treating breast cancer, highlighting their potential as molecular markers and drug targets.

Career Highlights

Gilbert Jay is currently associated with Origene Technologies, Inc., where he continues to innovate and contribute to the field of biotechnology. His work has been instrumental in advancing the understanding and treatment of various medical conditions.

Collaborations

He has collaborated with notable coworkers, including Xuan Li and Karl F Kovacs, further enhancing the impact of his research and inventions.

Conclusion

Gilbert Jay's contributions to biotechnology through his patents and innovative research have made a significant impact on medical science. His work continues to pave the way for advancements in diagnosis and treatment of critical health conditions.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…